Dr Leearne Hinch is a seasoned biotechnology CEO and entrepreneur with a proven track record in corporate strategy, business management, capital raising, investor relations, business development and partnering. She is CEO of INOVIQ Ltd (ASX: IIQ) that is pioneering next-generation diagnostics and therapeutics to enhance patient outcomes in cancer and neurodegenerative diseases. Leearne has successfully led INOVIQ’s transformation from a single-asset diagnostics company to a diversified biotech, through M&A, developing a robust cancer diagnostics and therapeutics pipeline, securing a global commercial partner for its proprietary exosome capture tools and building a strong team of 20 personnel. Leearne has strategic, commercial and technical experience leading the development and commercialization of diagnostics, therapeutics and veterinary pharmaceuticals. She has held past leadership roles as a biotechnology executive and consultant at Ingeneus Solutions, Eustralis Pharmaceuticals, OBJ and Holista Colltech. She holds a Bachelor of Science, Bachelor of Veterinary Medicine and Surgery and Master of Business Administration qualifications.
Listed skills include Strategy, Biotechnology, Commercialization, Start Ups, and 5 others.